Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human S100A8 Antibodies:
anti-Rat (Rattus) S100A8 Antibodies:
anti-Mouse (Murine) S100A8 Antibodies:
Go to our pre-filtered search.
Human Monoclonal S100A8 Primary Antibody for EIA, IHC (fro) - ABIN111891
Odink, Cerletti, Brüggen, Clerc, Tarcsay, Zwadlo, Gerhards, Schlegel, Sorg: Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. in Nature 1987
Show all 10 Pubmed References
Human Monoclonal S100A8 Primary Antibody for EIA, IHC (fro) - ABIN111890
Brandtzaeg, Jones, Flavell, Fagerhol: Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. in Journal of clinical pathology 1989
Show all 11 Pubmed References
Mouse (Murine) Polyclonal S100A8 Primary Antibody for IF (p), IHC (p) - ABIN749273
Nguyen, Fentress, Qiu, Yun, Cox, Chawla: Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. in Science (New York, N.Y.) 2013
Human Polyclonal S100A8 Primary Antibody for ELISA, WB - ABIN4242803
Eggers, Sikora, Lorenz, Taubert, Moobed, Baumann, Stangl, Stangl: RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1. in Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2011
Human Monoclonal S100A8 Primary Antibody for IA, FACS - ABIN2192036
Robinson, Tessier, Poulsom, Hogg: The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. in The Journal of biological chemistry 2002
Human Polyclonal S100A8 Primary Antibody for IHC, IHC (p) - ABIN4351730
Ellis, LaRocque, Uddin, Krastins, Mayo-Smith, Sarracino, Karlsson, Rahman, Shirin, Bhuiyan, Chowdhury, Khan, Ryan, Calderwood, Qadri, Harris: Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera. in Infection and immunity 2015
Low S100A8 expression is associated with head and neck neoplasms.
Report role of fecal calprotectin assay in the diagnosis and management of inflammatory bowel disease.
S100A8 and S100A9 (show S100A9 Antibodies) aggravate Coxsackievirus B3-induced myocarditis and might serve as therapeutic targets in inflammatory cardiomyopathies.
Data suggest that fecal calprotectin may be a potential biomarker to identify patients with ankylosing spondylitis (AS) at risk of developing inflammatory bowel disease (IBD).
Elevated S100A8 and S100A9 (show S100A9 Antibodies) gene expression in SP-infected HMEECs and in the middle ear mucosa of OM, minor co-localized with neutrophil markers suggests that middle ear epithelial cell secretion of S100A8 and S100A9 (show S100A9 Antibodies) may play a role in the pathogenesis of recurrent and chronic OM
results of this study support an additional role of calprotectin in assessing inflammatory activity in patients with RA
Data show that E3 ubiquitin ligase (show MUL1 Antibodies) HRD1 (HRD1 (show SYVN1 Antibodies)) decreased the protein level of S100A8 through ubiquitination.
High S100A8 expression is associated with glioblastoma.
This study implicates S100A8 and S100A9 (show S100A9 Antibodies) as important mediators of tumor cell aggressiveness, and highlights the therapeutic potential of S100A8 and S100A9 (show S100A9 Antibodies) for interference of metastasis.
Data indicate a statistical correlation between fecal calprotectin (FC) and gastrointestinal graft-versus-host disease (GvHD).
Data suggest that up-regulation of S100A8 and S100A9 (show S100A9 Antibodies) is a key component of early endometrial response to uterine involution in the post-partum period and to prevent chronic endometritis/uterine inflammation; up-regulation can be influenced by diet.
Study verified porcine calprotectin (S100A8/A9) expression at the protein level in multiple Haemophilus parasuis infected tissues and explored their molecular characterization.
theses findings reveal unexpected gene expression differences between WT and KO mice at a young age (in the absence of physiological stress), and address the hypothesis that Mrp8 and Mrp14 (show S100A9 Antibodies) accumulation promotes age-related inflammation
Neutrophil-derived S100A8/A9 promotes thrombocytosis in diabetic mice
Perinatal alarmins S100A8 and S100A9 (show S100A9 Antibodies) specifically altered MyD88 (show MYD88 Antibodies)-dependent proinflammatory gene programs. S100 programming prevented hyperinflammatory responses without impairing pathogen defense. TRIF (show RNF138 Antibodies)-adaptor-dependent regulatory genes remained unaffected by perinatal S100 programming and responded strongly to lipopolysaccharide, but were barely expressed.
S100a8 upregulation triggers NF-kappaB (show NFKB1 Antibodies) signal pathway through RAGE (show AGER Antibodies) and TLR4 (show TLR4 Antibodies), in response to laser-induced dermis wound healing.
Although MRP-8/-14 expression is highly increased in experimental, these proteins do not contribute to the pathogenesis in the effector phase of epidermolysis bullosa acquisita and bullous pemphigoid (show DST Antibodies).
TLR4 (show TLR4 Antibodies), TLR2 (show TLR2 Antibodies) also contributed to Mrp8-induced inflammatory response and tolerance.
S100A8 appears to play a crucial role in the activation of the TLR4 (show TLR4 Antibodies)/MD-2 (show LY96 Antibodies) pathway and the promotion of a tumor growth-enhancing immune microenvironment.
Rps14 (show RPS14 Antibodies) haploinsufficiency in del(5q) myelodysplastic syndrome is linked to activation of the innate immune system and induction of S100A8-S100A9 (show S100A9 Antibodies) expression, leading to a p53 (show TP53 Antibodies)-dependent erythroid differentiation defect.
S100A8 is primarily produced from CXCR2 (show CXCR2 Antibodies)-expressing CD11b (show ITGAM Antibodies)(+)Gr-1 (show GSR Antibodies)(high) cells, and it upregulates TNF-alpha (show TNF Antibodies) production in CD11b (show ITGAM Antibodies)(+)F4/80(+) cells through cellular cross-talk, which is an important mechanism in the development of Nonalcoholic fatty liver disease
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in the inhibition of casein kinase and as a cytokine. Altered expression of this protein is associated with the disease cystic fibrosis.
, S100 calcium-binding protein A8 (calgranulin A)
, calgranulin A
, calprotectin L1L subunit
, cystic fibrosis antigen
, leukocyte L1 complex light chain
, migration inhibitory factor-related protein 8
, protein S100-A8
, urinary stone protein band A
, S100 calcium binding protein A8 (calgranulin A)
, S100 calcium binding protein A8
, S100 calcium-binding protein A8
, neutrophil cytosolic 7 kDa protein
, chemotactic S100 protein
, chemotactic cytokine CP-10
, pro-inflammatory S100 cytokine
, macrophage migration inhibitory factor-related protein-8